185 related articles for article (PubMed ID: 10569179)
1. Differential changes in cardiac myofibrillar and sarcoplasmic reticular gene expression in alloxan-induced diabetes.
Golfman L; Dixon IM; Takeda N; Chapman D; Dhalla NS
Mol Cell Biochem; 1999 Oct; 200(1-2):15-25. PubMed ID: 10569179
[TBL] [Abstract][Full Text] [Related]
2. Influence of verapamil on some subcellular defects in diabetic cardiomyopathy.
Afzal N; Pierce GN; Elimban V; Beamish RE; Dhalla NS
Am J Physiol; 1989 Apr; 256(4 Pt 1):E453-8. PubMed ID: 2523196
[TBL] [Abstract][Full Text] [Related]
3. Sequence of alterations in subcellular organelles during the development of heart dysfunction in diabetes.
Takeda N; Dixon IM; Hata T; Elimban V; Shah KR; Dhalla NS
Diabetes Res Clin Pract; 1996 Feb; 30 Suppl():113-22. PubMed ID: 8964185
[TBL] [Abstract][Full Text] [Related]
4. Depressed levels of Ca2+-cycling proteins may underlie sarcoplasmic reticulum dysfunction in the diabetic heart.
Netticadan T; Temsah RM; Kent A; Elimban V; Dhalla NS
Diabetes; 2001 Sep; 50(9):2133-8. PubMed ID: 11522681
[TBL] [Abstract][Full Text] [Related]
5. Modification of cardiac subcellular remodeling due to pressure overload by captopril and losartan.
Liu X; Sentex E; Golfman L; Takeda S; Osada M; Dhalla NS
Clin Exp Hypertens; 1999; 21(1-2):145-56. PubMed ID: 10052650
[TBL] [Abstract][Full Text] [Related]
6. Cardiac membrane Ca(2+)-transport in alloxan-induced diabetes in rats.
Golfman LS; Takeda N; Dhalla NS
Diabetes Res Clin Pract; 1996 Jul; 31 Suppl():S73-7. PubMed ID: 8864644
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of changes in sarcoplasmic reticular gene expression in cardiac hypertrophy by propranolol and verapamil.
Takeo S; Elmoselhi AB; Goel R; Sentex E; Wang J; Dhalla NS
Mol Cell Biochem; 2000 Oct; 213(1-2):111-8. PubMed ID: 11129949
[TBL] [Abstract][Full Text] [Related]
8. Transgenic overexpression of the sarcoplasmic reticulum Ca2+ATPase improves reticular Ca2+ handling in normal and diabetic rat hearts.
Vetter R; Rehfeld U; Reissfelder C; Weiss W; Wagner KD; Günther J; Hammes A; Tschöpe C; Dillmann W; Paul M
FASEB J; 2002 Oct; 16(12):1657-9. PubMed ID: 12206992
[TBL] [Abstract][Full Text] [Related]
9. Subcellular remodeling and heart dysfunction in cardiac hypertrophy due to pressure overload.
Dhalla NS; Golfman L; Liu X; Sasaki H; Elimban V; Rupp H
Ann N Y Acad Sci; 1999 Jun; 874():100-10. PubMed ID: 10415524
[TBL] [Abstract][Full Text] [Related]
10. Improvement of defective sarcoplasmic reticulum Ca2+ transport in diabetic heart of transgenic rats expressing the human kallikrein-1 gene.
Tschöpe C; Spillmann F; Rehfeld U; Koch M; Westermann D; Altmann C; Dendorfer A; Walther T; Bader M; Paul M; Schultheiss HP; Vetter R
FASEB J; 2004 Dec; 18(15):1967-9. PubMed ID: 15448111
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of sarcoplasmic reticulum Ca(2+)-ATPase during progression of left ventricular hypertrophy.
Qi M; Shannon TR; Euler DE; Bers DM; Samarel AM
Am J Physiol; 1997 May; 272(5 Pt 2):H2416-24. PubMed ID: 9176313
[TBL] [Abstract][Full Text] [Related]
12. Cardiac myofibrillar and sarcoplasmic reticulum function are not depressed in insulin-resistant JCR:LA-cp rats.
Misra T; Gilchrist JS; Russell JC; Pierce GN
Am J Physiol; 1999 Jun; 276(6):H1811-7. PubMed ID: 10362658
[TBL] [Abstract][Full Text] [Related]
13. Decreased cardiac sarcoplasmic reticulum Ca2+ -ATPase activity contributes to cardiac dysfunction in streptozotocin-induced diabetic rats.
Zhao XY; Hu SJ; Li J; Mou Y; Chen BP; Xia Q
J Physiol Biochem; 2006 Mar; 62(1):1-8. PubMed ID: 16909926
[TBL] [Abstract][Full Text] [Related]
14. Increased inhibition of SERCA2 by phospholamban in the type I diabetic heart.
Vasanji Z; Dhalla NS; Netticadan T
Mol Cell Biochem; 2004 Jun; 261(1-2):245-9. PubMed ID: 15362510
[TBL] [Abstract][Full Text] [Related]
15. Long-term alcohol administration inhibits synthesis of both myofibrillar and sarcoplasmic proteins in heart.
Vary TC; Deiter G
Metabolism; 2005 Feb; 54(2):212-9. PubMed ID: 15690316
[TBL] [Abstract][Full Text] [Related]
16. Diabetic alterations in cardiac sarcoplasmic reticulum Ca2+-ATPase and phospholamban protein expression.
Kim HW; Ch YS; Lee HR; Park SY; Kim YH
Life Sci; 2001 Dec; 70(4):367-79. PubMed ID: 11798007
[TBL] [Abstract][Full Text] [Related]
17. Role of oxidative stress in ischemia-reperfusion-induced alterations in myofibrillar ATPase activities and gene expression in the heart.
Maddika S; Elimban V; Chapman D; Dhalla NS
Can J Physiol Pharmacol; 2009 Feb; 87(2):120-9. PubMed ID: 19234575
[TBL] [Abstract][Full Text] [Related]
18. Cardiac sarcoplasmic reticulum Ca(2+)-ATPase expression in streptozotocin-induced diabetic rat heart.
Zarain-Herzberg A; Yano K; Elimban V; Dhalla NS
Biochem Biophys Res Commun; 1994 Aug; 203(1):113-20. PubMed ID: 8074644
[TBL] [Abstract][Full Text] [Related]
19. Cardiac sarcolemmal Na(+)-Ca2+ exchange and Na(+)-K+ ATPase activities and gene expression in alloxan-induced diabetes in rats.
Golfman L; Dixon IM; Takeda N; Lukas A; Dakshinamurti K; Dhalla NS
Mol Cell Biochem; 1998 Nov; 188(1-2):91-101. PubMed ID: 9823015
[TBL] [Abstract][Full Text] [Related]
20. Renin-angiotensin blockade attenuates cardiac myofibrillar remodelling in chronic diabetes.
Machackova J; Liu X; Lukas A; Dhalla NS
Mol Cell Biochem; 2004 Jun; 261(1-2):271-8. PubMed ID: 15362513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]